- Home
- ELMD vs LSB Comparison
ELMD vs LSB Comparison
Compare ELMD & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELMD
- LSB
- Stock Information
- Founded
- ELMD 1992
- LSB 2002
- Country
- ELMD United States
- LSB China
- Employees
- ELMD N/A
- LSB N/A
- Industry
- ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- LSB
- Sector
- ELMD Health Care
- LSB
- Exchange
- ELMD Nasdaq
- LSB NYSE
- Market Cap
- ELMD 172.2M
- LSB 22.3M
- IPO Year
- ELMD 2010
- LSB N/A
- Fundamental
- Price
- ELMD $19.32
- LSB $1.10
- Analyst Decision
- ELMD Strong Buy
- LSB
- Analyst Count
- ELMD 1
- LSB 0
- Target Price
- ELMD $38.00
- LSB N/A
- AVG Volume (30 Days)
- ELMD 120.2K
- LSB 818.1K
- Earning Date
- ELMD 08-26-2025
- LSB 07-22-2025
- Dividend Yield
- ELMD N/A
- LSB N/A
- EPS Growth
- ELMD 60.99
- LSB N/A
- EPS
- ELMD 0.79
- LSB N/A
- Revenue
- ELMD $61,439,000.00
- LSB $79,415,311.00
- Revenue This Year
- ELMD $17.91
- LSB $39.33
- Revenue Next Year
- ELMD $11.70
- LSB $75.61
- P/E Ratio
- ELMD $24.25
- LSB N/A
- Revenue Growth
- ELMD 14.85
- LSB N/A
- 52 Week Low
- ELMD $13.74
- LSB $0.36
- 52 Week High
- ELMD $35.56
- LSB $6.82
- Technical
- Relative Strength Index (RSI)
- ELMD 37.60
- LSB 50.39
- Support Level
- ELMD $19.81
- LSB $0.93
- Resistance Level
- ELMD $21.20
- LSB $1.48
- Average True Range (ATR)
- ELMD 0.89
- LSB 0.11
- MACD
- ELMD -0.16
- LSB 0.03
- Stochastic Oscillator
- ELMD 2.52
- LSB 30.51
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About LSB LAKESHORE BIOPHARMA CO LTD
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.